NAFLD is associated with a highly atherogenic lipoprotein profile, characterized by high serum TG, low-density lipoprotein (LDL-C), and apolipoprotein B (ApoB) concentrations and a low HDL-C concentration [7, 8]. The gene discussed is APOB; the disease is metabolic dysfunction-associated steatotic liver disease.